SESSION TITLE: Evaluation and Treatment of ILD
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a debilitating, progressive, unpredictable and fatal fibrotic lung disease requiring early intervention to improve outcomes. The objective of this study was to understand the mortality risk of patients with IPF compared with matched controls in the Medicare population.